| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 武煜 | 招银国际 | 医药生物 | 31.11% | 31.17% | 18.07% | -33.33% | 2 | -16.66% | 2025-05-30 |
| 2 | 华挺 | 财通证券 | 医药生物 | 31.07% | 35.29% | 8.01% | -6.67% | 7 | -50.33% | 2025-07-11 |
| 3 | 袁聪敏 | 中信证券 | 医药生物 | 31.05% | 24.71% | 31.05% | 100.00% | 5 | 0.00% | 2025-04-01 |
| 4 | 阳景 | 浦银国际证券 | 医药生物 | 31.04% | 29.96% | 9.77% | 100.00% | 4 | 0.00% | 2025-06-17 |
| 5 | 仰佳佳 | 申万宏源 | 医药生物 | 31.03% | 31.00% | -3.20% | 23.08% | 1 | -37.64% | 2025-07-22 |
| 6 | 袁聪敏 | 中信证券 | 医药生物 | 31.01% | 24.67% | 22.82% | 100.00% | 3 | 0.00% | 2025-04-29 |
| 7 | 袁聪敏 | 中信证券 | 医药生物 | 30.97% | 24.64% | 23.24% | 100.00% | 5 | 0.00% | 2025-04-25 |
| 8 | 张林晚 | 上海证券 | 医药生物 | 30.97% | 34.62% | 20.00% | -100.00% | 1 | -18.93% | 2025-07-02 |
| 9 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 30.96% | 31.29% | 37.62% | 12.50% | 2 | -27.10% | 2025-04-10 |
| 10 | 仰佳佳 | 申万宏源 | 医药生物 | 30.93% | 32.17% | 31.86% | 23.08% | 3 | -37.64% | 2025-04-25 |
| 11 | 任晓帆 | 东海证券 | 医药生物 | 30.88% | 29.50% | 33.23% | 0.00% | 2 | -17.50% | 2025-07-16 |
| 12 | 袁聪敏 | 中信证券 | 医药生物 | 30.84% | 24.51% | 22.66% | 100.00% | 5 | 0.00% | 2025-04-28 |
| 13 | 华挺 | 财通证券 | 医药生物 | 30.79% | 24.88% | 18.02% | -6.67% | 4 | -50.33% | 2025-06-13 |
| 14 | 张林晚 | 上海证券 | 医药生物 | 30.78% | 23.85% | 21.49% | -100.00% | 1 | -18.93% | 2025-06-18 |
| 15 | 仰佳佳 | 申万宏源 | 医药生物 | 30.69% | 27.84% | 15.25% | 23.08% | 1 | -37.64% | 2025-06-27 |
| 16 | 任晓帆 | 东海证券 | 医药生物 | 30.68% | 32.79% | 33.03% | 0.00% | 2 | -17.50% | 2025-07-09 |
| 17 | 刘鹏 | 长城证券 | 医药生物 | 30.66% | 29.19% | 1.58% | -5.88% | 12 | -72.34% | 2017-12-29 |
| 18 | 华挺 | 财通证券 | 医药生物 | 30.61% | 24.39% | 15.42% | -6.67% | 4 | -50.33% | 2025-06-11 |
| 19 | 吴春红 | 江海证券 | 医药生物 | 30.56% | 16.93% | 8.90% | 27.27% | 6 | -25.67% | 2025-06-16 |
| 20 | 仰佳佳 | 申万宏源 | 医药生物 | 30.46% | 29.11% | 20.55% | 23.08% | 1 | -37.64% | 2025-06-06 |